SINTX TECHNOLOGIES, INC.

SINT Healthcare Medical Devices

SINTX TECHNOLOGIES, INC.’s revenue for fiscal 2025 (year ended December 2025) was $1.0 million, down 64.7% from fiscal 2024.

Revenue
+952.9%
EPS
+93.1%
Free cash flow
+47.4%
Total debt
−6.78%

Quarter to September 2026, against a year earlier

1.56 0.06 −3.70%
Market cap
$11.5M
P/E
0.0×
Fwd P/E
−0.9×
Dividend yield
—
F-score
2/9
Altman Z
−45.42
Beneish M
−3.03
Dividend safety
n/a
Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21 Dec '22 Dec '23 Dec '24 Dec '25
P/E ratio
0.00 — 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Piotroski F-Score
5 — — — 3 2 4 4 5 2
Altman Z-Score
(11.58) — — (37.52) (7.69) (14.96) (25.46) (27.03) (45.92) (45.42)
P/S ratio
472,387.34 — 0.00 4.33 42.29 25.42 1.85 0.65 1.64 10.52
Altman Z″-Score (non-manufacturers)
(27.90) — (67.09) (85.45) (16.53) (33.07) (58.84) (60.76) (105.09) (105.96)
P/FCF ratio
0.00 — 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
P/Operating CF
(3,759,837.74) — 0.00 (1.92) (12.22) (6.47) (1.38) (0.54) (4.21) (4.57)
Beneish M-Score
(4.20) — — 3.88 (3.06) (0.90) (1.96) 0.78 (4.22) (3.03)
P/B ratio
640,193.11 — 0.00 0.57 0.97 0.90 0.50 0.19 1.21 3.66
EV/Sales
472,387.35 — (0.41) 1.76 0.28 5.84 (1.82) (0.60) 0.41 6.47
EV/EBITDA
0.00 — 0.40 0.00 0.00 0.00 0.27 0.14 0.00 0.00
EV/FCF
(923,663.76) — 0.59 (0.19) (0.02) (0.26) 0.24 0.11 (0.13) (0.78)
Current Ratio
1.14 0.44 2.95 1.97 9.58 5.47 0.89 1.90 2.28 1.51
Net Debt/EBITDA
(0.01) (0.01) 0.41 0.29 3.12 1.19 0.55 0.28 0.28 0.41
Debt/Equity
0.62 0.11 0.02 0.00 0.02 0.14 0.09 0.01 0.01 0.00
ROE
(165.24%) (111.88%) (325.87%) (110.29%) (107.04%) (43.30%) (144.02%) (114.47%) (174.07%) (500.75%)
ROA
(67.74%) (45.62%) (172.44%) (72.60%) (83.82%) (35.61%) (87.68%) (53.21%) (88.98%) (180.59%)
ROIC
(63.62%) (84.93%) (262.66%) (120.05%) (626.03%) (124.55%) 0.00% (152.41%) (2,676.64%) 0.00%
Return on Tangible Assets
(729.07%) 212.89% (473.68%) (342.94%) (65.90%) (57.09%) (341.95%) (111.18%) (318.52%) (713.87%)
Average Days of Receivables
38.83 0.00 1,010.47 72.05 25.19 61.44 76.69 95.18 24.78 63.82
Earnings Yield
(86.67%) — (2,033.20%) (424.97%) (126.95%) (58.88%) (420.87%) (524.08%) (620.13%) (161.64%)
Free Cash Flow Yield
0.00% — 0.00% (218.09%) (37.91%) (89.43%) (406.84%) (862.38%) (197.97%) (79.00%)
Free Cash Flow per Share
(3,026,545.92) (943,844.67) 0.00 (84,602.19) (11,546.60) (11,439.17) (7,736.48) (781.60) (12.56) (3.03)
Book value per Share
4,366,667.96 1,096,116.66 0.00 66,864.27 31,455.72 14,329.17 3,782.37 469.09 5.25 1.06
Free Cash Flow
(7.79) (4.69) (9.41) (6.58) (9.47) (13.73) (11.67) (14.62) (9.31) (8.41)
EV/EBIT
0.00 — 0.40 0.00 0.00 0.00 0.25 0.12 0.00 0.00
Other line items

Show all line items

Columns are period end dates · fundamentals updated 5 Nov 2026